Zobrazeno 1 - 10
of 2 324
pro vyhledávání: '"Clinical Cancer Research"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Purpose High‐quality communication is essential to patient‐centered care. Existing communication models and research tends to focus on what is said verbally with little attention to nonverbal aspects of communication. In sensitive and em
Externí odkaz:
https://doaj.org/article/f8cafccd24f2416dbadaa28070eb4cb4
Autor:
Yasuyuki Ikezawa, Ryo Morita, Hidenori Mizugaki, Kazunari Tateishi, Keiki Yokoo, Toshiyuki Sumi, Hajime Kikuchi, Yasuo Kitamura, Atsushi Nakamura, Maki Kobayashi, Mari Aso, Nozomu Kimura, Fumiaki Yoshiike, Furuta Megumi, Hisashi Tanaka, Motoki Sekikawa, Tsutomu Hachiya, Keiichi Nakamura, Fumihiro Hommura, Noriaki Sukoh, Kenichiro Ito, Takashi Kikuchi, Toshihiko Agatsuma, Hiroshi Yokouchi
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Selecting pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum‐based chemotherapy (COMB) for patients with nonsmall cell lung cancer (NSCLC) and high programmed death‐ligand 1 (PD‐L1) expression is an important is
Externí odkaz:
https://doaj.org/article/9abe2da6e7c64c909348f0fdd32c3056
Autor:
Rebekah M. Summey, Erica Gornstein, Brennan Decker, Kali C. Dougherty, Janet S. Rader, Elizabeth Hopp
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Objective The objective of this study was to assess the frequency of potential germline pathogenic variants that may contribute to risk of development of adult granulosa cell tumors (AGCT) given the paucity of germline testing guidelines for
Externí odkaz:
https://doaj.org/article/88b7c71b62fa4d02a01315394a1a0de6
Autor:
Juliane Manitz, Aslihan Gerhold‐Ay, Pascal Kieslich, Parantu Shah, Thomas Mrowiec, Karin Tyroller
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Avelumab first‐line (1 L) maintenance is a standard of care for advanced urothelial carcinoma (aUC) based on the JAVELIN Bladder 100 phase 3 trial, which showed that avelumab 1 L maintenance + best supportive care (BSC) signific
Externí odkaz:
https://doaj.org/article/f5e67ed43d5e43618b9bcb2460270286
Autor:
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih‐Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya‐Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer Ajani
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Background First‐line nivolumab plus chemotherapy and nivolumab plus ipilimumab both demonstrated significant overall survival (OS) benefit versus chemotherapy in previously untreated patients with advanced esophageal squamous cell carcino
Externí odkaz:
https://doaj.org/article/59c4231e83f941f6a4719927e06f1ef1
Autor:
Yukihito Kajita, Shuhei Teranishi, Tomoe Sawazumi, Haruka Watanabe, Satoshi Nagaoka, Anna Tanaka, Yuichirou Suzukawa, Yuto Motobayashi, Tomofumi Hirose, Chihiro Maeda, Kenichi Seki, Ken Tashiro, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Yoshiaki Inayama, Takeshi Kaneko
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19512-19522 (2023)
Abstract Background Personalized treatment for non‐small cell lung cancer (NSCLC) has advanced rapidly, and elucidating the genetic changes that trigger this disease is crucial for appropriate treatment selection. Both slow‐pull and aspiration me
Externí odkaz:
https://doaj.org/article/782609302b4245d280877c2f37c7f884
Autor:
Megan A. Mullins, Lisa Reber, Ariel Washington, Marina Stasenko, Aaron Rankin, Christopher R. Friese, Mary E. Cooley, Matthew F. Hudson, Lauren P. Wallner
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 19203-19214 (2023)
Abstract Background Sexual orientation and gender identity (SOGI) data collection in community oncology practices is critical to identify and address cancer inequities, but less than 20% of NCI Community Oncology Research Program (NCORP)‐affiliated
Externí odkaz:
https://doaj.org/article/41c4bd817aab42849b1e725470b8d29a
Autor:
Eriko Murakami, Hiroaki Akamatsu, Shunsuke Teraoka, Toshiaki Takakura, Eri Takase, Masanori Tanaka, Takahiro Kaki, Yuhei Harutani, Katsuyuki Furuta, Takeya Sugimoto, Ryota Shibaki, Daichi Fujimoto, Atsushi Hayata, Yuichi Ozawa, Masanori Nakanishi, Yasuhiro Koh, Toshio Shimokawa, Nobuyuki Yamamoto
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background Mannitol is exclusively recommended in the National Comprehensive Cancer Network guidelines for diuresis in cisplatin (CDDP)‐based chemotherapy. The utility of furosemide, a widely used and convenient diuretic, thus requires cla
Externí odkaz:
https://doaj.org/article/936934c8acbe4ec093a80de605ccb236
Autor:
Yan Hiu Athena Lee, Jeffrey Shi Kai Chan, Jeremy Man Ho Hui, Pias Tang, Kang Liu, Edward Christopher Dee, Kenrick Ng, Gary Tse, Chi Fai Ng
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background This study aimed to examine the associations between the use of statins concurrent with androgen deprivation therapy (ADT) and the risks of mortality in Asian patients diagnosed with prostate cancer (PCa). Methods Adult patients (
Externí odkaz:
https://doaj.org/article/8e3503aca7224c808834dd2f6bb7100c
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 17273-17283 (2023)
Abstract Objective This study sought to investigate interactive participation and content of a moderated discussion forum within a web‐based psychoeducational intervention aimed at alleviating sexual dysfunction and fertility distress in young adul
Externí odkaz:
https://doaj.org/article/b3098f2809e64bbf8fbc8cfb8d442225